Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise as supportive care in advanced cancer-related weight loss: a feasibility study comparing patients with and without severe weight loss.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer.

Nature·2026
Same author

Analysis of the relationship between body composition and the pharmacokinetics of panitumumab in the treatment of localized squamous cell carcinoma of the anus - An ancillary study of the FFCD0904 phase I and II trial.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Efficacy of haemostatic radiotherapy for bleeding related to nonoperable advanced gastric cancer.

Clinics and research in hepatology and gastroenterology·2026
Same author

Can we predict regression of anal high-grade squamous intraepithelial lesions using molecular biomarkers?

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2025
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 29, 2010

[Colorectal carcinogenesis: update].

Astrid Lièvre1, Pierre Laurent-Puig

  • 1U490 Laboratoire de toxicologie moléculaire, 45, rue des Saints-Péres, 75006 Paris.

La Revue Du Praticien
|April 17, 2004
PubMed
Summary
This summary is machine-generated.

Colorectal cancer arises from chromosomal or genetic instability, often linked to hereditary syndromes. Despite differing mechanisms, key signaling pathways like APC/beta-catenin are crucial for tumor development and patient management.

More Related Videos

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

Related Experiment Videos

Last Updated: May 25, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 29, 2010

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

Area of Science:

  • Molecular biology
  • Oncology
  • Genetics

Background:

  • Colorectal cancer (CRC) pathogenesis involves distinct molecular mechanisms, including chromosomal instability (CIN) and genetic instability (GIN).
  • Hereditary syndromes, such as familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC) syndrome, significantly increase predisposition to CRC.
  • Understanding these molecular underpinnings is vital for advancing CRC research and clinical practice.

Purpose of the Study:

  • To elucidate the molecular mechanisms driving colorectal carcinogenesis.
  • To identify common signaling pathways involved in malignant transformation despite differing instability types.
  • To highlight the importance of molecular classification for understanding tumor development and patient management.

Main Methods:

  • Review of recent molecular biology findings on colorectal carcinogenesis.
  • Identification of key molecular mechanisms: chromosomal instability and genetic instability.
  • Analysis of hereditary syndromes predisposing to colorectal cancer.

Main Results:

  • Two primary molecular mechanisms, chromosomal instability and genetic instability, are implicated in colorectal carcinogenesis.
  • Familial adenomatous polyposis and hereditary non-polyposis colorectal cancer syndrome are key hereditary predispositions.
  • Common signaling pathways, including APC/beta-catenin, TGFbeta, RAS, and TP53, are involved in malignant transformation, irrespective of the initial instability mechanism.

Conclusions:

  • A unified understanding of signaling pathways is emerging in colorectal cancer, despite diverse initiating molecular events.
  • Molecular classification of colorectal cancers offers critical insights into tumor development.
  • This molecular understanding is essential for improving patient management strategies in colorectal cancer.